PWMG
BIIB icon

Prestige Wealth Management Group’s Biogen BIIB Stock Holding History

Prestige Wealth Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.6K Buy
350
+4
+1% +$765 0.01% 235
2026
Q1 		$63.4K Hold
346
– – 0.01% 234
2025
Q4 		$60.9K Buy
346
+282
+441% +$46.1K 0.01% 233
2025
Q3 		$8.97K Buy
64
+26
+68% +$3.51K ﹤0.01% 470
2025
Q2 		$4.77K Buy
38
+3
+9% +$374 ﹤0.01% 568
2025
Q1 		$4.79K Hold
35
– – ﹤0.01% 569
2024
Q4 		$5.35K Sell
35
-4
-10% -$675 ﹤0.01% 581
2024
Q3 		$7.56K Sell
39
-14
-26% -$2.93K ﹤0.01% 514
2024
Q2 		$12.3K Sell
53
-10
-16% -$2.17K ﹤0.01% 378
2024
Q1 		$13.6K Sell
63
-3
-5% -$703 ﹤0.01% 399
2023
Q4 		$17.1K Buy
66
+15
+29% +$3.68K ﹤0.01% 357
2023
Q3 		$13.1K Buy
51
+5
+11% +$1.34K ﹤0.01% 396
2023
Q2 		$13.1K Buy
46
+14
+44% +$4.17K ﹤0.01% 418
2023
Q1 		$8.9K Sell
32
-5
-14% -$1.38K ﹤0.01% 455
2022
Q4 		$10.2K Sell
37
-1
-3% -$282 ﹤0.01% 462
2022
Q3 		$10K Buy
38
+3
+9% +$637 ﹤0.01% 411
2022
Q2 		$7K Hold
35
– – ﹤0.01% 492
2022
Q1 		$7K Sell
35
-3
-8% -$652 ﹤0.01% 529
2021
Q4 		$9K Buy
38
+1
+3% +$257 ﹤0.01% 495
2021
Q3 		$10K Hold
37
– – ﹤0.01% 482
2021
Q2 		$13K Sell
37
-17
-31% -$5.15K ﹤0.01% 424
2021
Q1 		$15K Sell
54
-1
-2% -$270 ﹤0.01% 394
2020
Q4 		$13K Buy
55
+30
+120% +$7.74K ﹤0.01% 406
2020
Q3 		$7K Hold
25
– – ﹤0.01% 487
2020
Q2 		$7K Sell
25
-169
-87% -$50.8K ﹤0.01% 471
2020
Q1 		$62K Sell
194
-1,122
-85% -$340K 0.03% 157
2019
Q4 		$390K Sell
1,316
-16
-1% -$4.44K 0.21% 75
2019
Q3 		$310K Sell
1,332
-50
-4% -$11.6K 0.18% 85
2019
Q2 		$323K Buy
1,382
+419
+44% +$96.7K 0.2% 79
2019
Q1 		$227K Sell
963
-53
-5% -$16.7K 0.14% 107
2018
Q4 		$306K Buy
+1,016
New +$324K 0.23% 80

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prestige Wealth Management Group's BIIB Position: Q2 2026 in Review

Prestige Wealth Management Group increased its Biogen (BIIB) stake by 1.2% in Q2 2026, buying an estimated $765 and bringing the position to 350 shares worth $75.6K. The position accounts for 0.01% of the portfolio, ranked #235.

Prestige Wealth Management Group first reported a position in BIIB in Q4 2018 and has held it in 31 quarters since. The position peaked at $390K in Q4 2019. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Prestige Wealth Management Group held 350 shares of Biogen worth $75.6K as of Q2 2026.
  • Prestige Wealth Management Group bought 4 Biogen shares in Q2 2026, an estimated $765.
  • Biogen made up 0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #235 holding.
  • Prestige Wealth Management Group first reported a position in Biogen in Q4 2018 and has held it in 31 quarters since.
  • Prestige Wealth Management Group's Biogen position peaked at $390K in Q4 2019.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.